~~<i id='AFD336BC9A'><strike id='AFD336BC9A'><tt id='AFD336BC9A'><pre id='AFD336BC9A'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：Wikipedia 2025-09-29 09:39:51 Page View：78328

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Meta's Zuckerberg and Chan on track to put $50 billion into science
Next article： Peter Hotez and the public health issue of online harassment

knowledge

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Physician subsidies by hospitals soar in wake of No Surprises Act

AdobePhysicianstaffingfirms,flailinginthewakeofafederallawbanningsurprisebills,aredemandingextrapaym

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

Supreme Court to hear if Covid misinformation is protected speech

MANDELNGAN/AFPviaGettyImagesWASHINGTON—Associalmediasiteswerefloodedwithmisleadingpostsaboutvaccines